The effect of angiotensin converting enzyme (ace) i/d polymorphism on atherosclerotic cardiovascular disease and cardiovascular mortality risk in non-hemodialyzed chronic kidney disease: the mediating role of plasma ace level

HIGHLIGHTS

  • who: Hendri Susilo et al. from the Department of Cardiology and Vascular Medicine, Universitas Airlangga Hospital, Surabaya, Indonesia Division of Science, Manchester Academic Health Science Centre, University of Manchester have published the article: The Effect of Angiotensin Converting Enzyme (ACE) I/D Polymorphism on Atherosclerotic Cardiovascular Disease and Cardiovascular Mortality Risk in Non-Hemodialyzed Chronic Kidney Disease: The Mediating Role of Plasma ACE Level, in the Journal: Genes 2022, 13, x FOR PEER REVIEW of 14/05/2022
  • what: The authors aimed to analyze the association between and mortality risk among non-hemodialyzed chronic kidney . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?